TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women

European Journal of Cancer Prevention

Volumn 18, Issue 4, 2009, Pages 285-290

  Li, Lihua ^a   Zhou, Xike ^a   Huang, Zhaohui ^a   Liu, Zhihui ^a   Song, Mingxu ^a   Guo, Zijian ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Breast cancer susceptibility; Genotype distributions; Haplotypes; Single nucleotide polymorphisms; TNRC9 LOC643714

Indexed keywords

ESTROGEN RECEPTOR; GENOMIC DNA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROL GROUP; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; PATHOLOGY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRINUCLEOTIDE REPEAT CONTAINING 9 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 68649114791     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832bf421     Document Type: Article

References (19)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130. (Pubitemid 36530000)
2. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. (2008). Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82:937-938.
3. Collaborative Group on Hormonal Factors in Breast Cancer (2001). Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358:1389-1399.
4. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1095.
5. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP (1991). Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51:6094-6097.
6. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. (2008). Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 25:e1000054.
7. Huijts PE, Vreeswijk MP, Kroeze-Jansema KH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, et al. (2007). Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases. Breast Cancer Res 9:R78.
8. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71. (Pubitemid 24345325)
9. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics 2002. CA Cancer J Clin 55:74-108.
10. Peto J, Mack TM (2000). High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411-414.
11. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. (2006). Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694-1706. (Pubitemid 44942707)
12. Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, et al. (2005). Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14:555-563. (Pubitemid 40277471)
13. Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, et al. (2006). Genes associated with breast cancer metastatic to bone. J Clin Oncol 24:2261-2267. (Pubitemid 46630655)
14. Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, et al. (2005). Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai. Zhonghua Yi Xue Za Zhi 85:3030-3034.
15. Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, et al. (2006). BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:27-31. (Pubitemid 43241928)
16. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39:865-869. (Pubitemid 47014497)
17. Tian FG, Guo XY, Zhang HY (2005). Advancement in diagnosis and treatment of breast cancer. Cancer Res Clin 17:58-60.
18. Wang SM (2007). Concerns on diagnosis and treatment of breast cancer in China. Chin Med J (Engl) 120:1741-1742. (Pubitemid 350111075)
19. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792. (Pubitemid 26004412)